Clinical trial
Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During…
NCT00115206 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00115206 |
|---|---|
| Title | Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy |
| Official title | A Pilot Study of the Effects of Neutropenia on Patient Reported Outcomes During Chemotherapy With or Without Neulasta® (Pegfilgrastim) in Subjects With Advanced NSCLC |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Neulasta® (pegfilgrastim) |
| Start date | Jul 1, 2002 |
| Completion | Jul 1, 2004 |
| First posted | Jun 22, 2005 |
| Last update posted | Apr 6, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: